SEC Form 4 · accession 0001209191-16-138764
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Aug 24, 2016
Accepted (ET)
Aug 26, 2016 · 1:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2016 | M | 6,500 | $36.30 | A | 274,725 | D | |
| Common StockF2,F3 | Aug 24, 2016 | S | 1,100 | $96.73 | D | 273,625 | D | |
| Common StockF2,F4 | Aug 24, 2016 | S | 1,000 | $98.74 | D | 272,625 | D | |
| Common Stock | Aug 24, 2016 | S | 100 | $99.50 | D | 272,525 | D | |
| Common StockF2,F5 | Aug 24, 2016 | S | 1,500 | $101.21 | D | 271,025 | D | |
| Common StockF2,F6 | Aug 24, 2016 | S | 2,800 | $101.83 | D | 268,225 | D | |
| Common Stock | Aug 24, 2016 | S | 100 | $100.02 | D | 79,100 | I | Common Stock Held In Trust |
| Common StockF2,F7 | Aug 24, 2016 | S | 900 | $101.60 | D | 78,200 | I | Common Stock Held In Trust |
| Common Stock | holding | — | — | — | 13,286 | I | 401k |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F8 | $36.30 | Aug 24, 2016 | M | 6,500 | D | — | Jan 23, 2017 | Common Stock | 6,500 | 131,500 | D |
Explanation of responses
- F1Transaction made pursuant to the holder's company approved trading plan under Rule 10b5-1.
- F2The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F3Open market sales reported on this line occurred at a weighted average price of $96.73 (range $96.40 to $97.37).
- F4Open market sales reported on this line occurred at a weighted average price of $98.74 (range $98.37 to $99.19).
- F5Open market sales reported on this line occurred at a weighted average price of $101.21 (range $100.63 to $101.60).
- F6Open market sales reported on this line occurred at a weighted average price of $101.83 (range $101.63 to $102.45).
- F7Open market sales reported on this line occurred at a weighted average price of $101.60 (range $101.25 to $102.00).
- F8Fully vested.